NCT04613895View on ClinicalTrials.gov

Treatment Effect According to Timing of Administration of DWP14012 40 mg

NAUnknownINTERVENTIONAL
Enrollment

186

Participants

Timeline

Start Date

November 17, 2020

Primary Completion Date

May 30, 2021

Study Completion Date

December 30, 2021

Conditions
Erosive Esophagitis
Interventions
DRUG

DWP14012

DWP14012 40 mg, orally, once daily just after a meal up to 4 weeks

DRUG

DWP14012

DWP14012 40 mg, orally, once daily before a meal up to 4 weeks

Trial Locations (1)

04763

Hanyang University Medical Center, Seoul

Sponsors
All Listed Sponsors
collaborator

Hanyang University

OTHER

lead

Daewoong Pharmaceutical Co. LTD.

INDUSTRY